Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Embryonic antigens and tumor cell cytolysis

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Chism SE, Burton RC, Warner NL (1978) Immunogenicity of oncofetal antigens: A review. Clin Immunol Immunother 11:346–373

  2. 2.

    Della-Porta G, Canevari S, Fossati G (1973) Immune responses to tumor and embryo cells in patients with mammary carcinoma. Br J Cancer 28:103–107

  3. 3.

    Ederer F, Mersheimer WL (1962) Sex differences in the survival of lung cancer patients. Cancer 15:425–432

  4. 4.

    Gangal SG, Agashe SS, Nair PNM, Rao RS, Ranadive KJ (1975) Onco-foetal cross reactivity between human osteogenic sarcoma and foetal periosteal fibroblasts grown in vitro. Indian J Med Res 63:851–857

  5. 5.

    Gautam S, Deodhar SD (1979) Effect of syngeneic fetal cell immunization on tumor growth and metastases. Proc Am Assoc Cancer Res 20:14

  6. 6.

    Godwin JD, Brown CC (1975) Some prognostic factors in survival of patients with cancer of the colon rectum. J Chronic Dis 28:441–454

  7. 7.

    Hersey P, Honeyman M, Edwards A, Adams E, McCarthy WH (1976) Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera. Int J Cancer 18:564–568

  8. 8.

    Hersey P, Stone DE, Morgan G, McCarthy WM, Milton GW (1977a) Previous pregnancy as a protective factor against death from melanoma. Lancet 1977 I, 451–452

  9. 9.

    Humphrey JM, Dourmashkin RR (1965) Electron microscope studies of immune cell lysis. In: Wolstenholme GEW, Knight J (eds) Complement, CIBA Foundation Symposium. Little Brown and Co, Boston, pp 175–186

  10. 10.

    Irie RF (1980) Oncofetal antigen (OFA-I): A human tumor-associated fetal antigen immunogenic in man. In: Rosenberg S (ed) Prospectives of immunology. Academic, New York (in press)

  11. 11.

    Irie RF, Irie K, Morton DL (1976) A membrane antigen common to human cancer and fetal brain tissues. Cancer Res 36:3510–3517

  12. 12.

    Irie RF, Giuliano AE, Morton DL (1979) Oncofetal antigen: A tumor associated fetal antigen immunogenic in man. J Natl Cancer Inst 63:367–373

  13. 13.

    Juusela H (1978) Renal adenocarcinoma: Clinical features and factors correlating to survival in 173 patients. A clinical investigation. Ann Chir Gynaecol 67:1–43

  14. 14.

    LeMevel BP, Wells SA (1973) Foetal antigens cross-reactive with tumour-specific transplantation antigens. Nature (New Biol) 244:183–184

  15. 15.

    Magnus K, Phil D (1977) Prognosis in malignant melanoma of the skin. Cancer 40:389–397

  16. 16.

    Medawar PB, Hunt R (1978) Vulnerability of methylcholanthrene-induced tumors to immunity aroused by syngeneic foetal cells. Nature 271:164–165

  17. 17.

    Old LJ, Stockert E, Boyse EA, Kim JH (1968) Antigenic modulation. J Exp Med 127:523–539

  18. 18.

    Olsen F (1966) The malignant melanoma of the skin. Acta Chir Scand (Suppl) 365:1–203

  19. 19.

    Parmiani G, Lembo R (1972) In: Anderson NG, Coggin JH, Cole E, Molleman JW (eds) Embryonic and fetal antigens in cancer. National Technical Information Service, Springfield pp 151

  20. 20.

    Rosenberg SA, Parker CA, Thorpe WP (1978) Expression of oncofetal antigens by murine and human normal cells in tissue culture. Isr J Med Sci 14:98–104

  21. 21.

    Salber EJ, Trichopoulos D, MacMahon B (1969) Lactation and reproductive histories of breast cancer patients in Boston, 1965–1966. J Natl Cancer Inst 43:1013–1024

  22. 22.

    Salinas FA, Silver HKB, Sheikh KM, Chandor SB (1978) Natural occurrence of human tumor-associated anti-fetal antibodies during normal pregnancy. Cancer 42:1653–1659

  23. 23.

    Schöne G (1906) Münchener Medizinische Wochenschrift 51:1

  24. 24.

    Seibert E, Sorg C, Happle R, Macher E (1977) Membrane-associated antigens of human malignant melanoma. Specificity of human sera reacting with cultured melanoma cells. Int J Cancer 19:172

  25. 25.

    Shapiro S, Strax P, Venet L, Fink R (1968) The search for risk factors in breast cancer. Am J Pub Health 58:820–834

  26. 26.

    Shaw HM, Milton GW, Farago G, McCarthy WH (1978) Endocrine influences on survival from malignant melanoma. Cancer 42:669–677

  27. 27.

    Sidell N, Irie RF, Morton DL (1979) Immune cytolysis of human malignant melanoma by antibody to oncofetal antigen-I (OFA-I). Complement-dependent cytotoxicity. Cancer Immunol Immunother 7:151–155

  28. 28.

    Tompkins WAF, Schmale JD, Mock R, Tick NT, Lock T, Sidell N, Palmer JL (1979) Neuraminidase augmented anti-CEA complement lysis of human colon tumor cells: Lack of correlation with anti-CEA mediated K-cell lysis and I-125 binding. J Natl Cancer Inst 62:503

Download references

Author information

Additional information

Reprint requests should be sent to: Division of Oncology, 54-140 CHS, UCLA School of Medicine, Los Angeles, CA 90024, USA

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jones, P.C., Sidell, N. & Irie, R.F. Embryonic antigens and tumor cell cytolysis. Cancer Immunol Immunother 8, 211–214 (1980). https://doi.org/10.1007/BF00206037

Download citation